Xeris Biopharma Holdings, Inc. (XERS)
5.44
-0.14
(-2.51%)
USD |
NASDAQ |
Mar 20, 16:00
5.445
0.00 (0.00%)
After-Hours: 20:00
Xeris Biopharma Holdings Research and Development Expense (Quarterly) : 7.874M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 64.86M |
| Zoetis, Inc. | 199.00M |
| Harrow, Inc. | 3.273M |
| Zymeworks, Inc. | 31.24M |
| Vir Biotechnology, Inc. | 85.53M |